The contrast injector market is expected to be worth $636.1 million by 2021, according to a market research report published by MarketsandMarkets. The report studies the global market for the forecast period of 2016 to 2021. The report analyzes and studies the major market drivers, restraints/challenges, and opportunities.
The market is expected to grow at a compound annual growth rate of 7.4 percent from 2016 to 2021, according to MarketsandMarkets.
On the basis of product, the contrast injector market is categorized into injector systems, consumables and accessories.
In 2016, the consumables segment was estimated to account for the largest share of the contrast injector market.
“This growth is mainly attributed to the recurring use of consumables in diagnostic procedures to maintain hygienic conditions. The injector systems segment is further divided into CT injector systems, MRI injector systems, and angiography injector systems,” according to MarketsandMarkets.
In 2016, the CT injector systems segment was expected to command the largest share of the market. The MRI injector systems segment is expected to grow at the highest CAGR during the forecast period.
The consumables segment is further divided into injector heads, syringes, tubing and other consumables (scan bags, valves, vials, and spikes). In 2016, the injector heads segment was estimated to account for the largest share of the consumables market.
The injector heads segment is further categorized into single head injectors, dual head injectors, and syringeless injectors. The single head injectors segment was expected to command the largest share of the market in 2016.
“The syringeless injectors segment is projected to grow at the highest CAGR during the forecast period,” according to MarketsandMarkets.
On the basis of application, the contrast media injector market is segmented into radiology, interventional cardiology and interventional radiology.
In 2016, the radiology segment was estimated to command the largest share of the contrast injector market. The interventional cardiology segment is expected to grow at the highest CAGR during the forecast period.
In another report, Research and Markets forecasts that the global contrast injector market is poised to grow at a CAGR of around 6.1 percent over the next several years to reach approximately $6.82 billion by 2025.
“Some of the prominent trends that the market is witnessing are IT-enabled solutions for contrast media injectors, development of gamma and neutron imaging solutions, high prevalence of cardiovascular and neurological disorders and growth opportunities/investment opportunities,” according to the Research and Markets report.
Some of the key players in the global contrast injector market include Bracco Imaging S.p.A., Bayer HealthCare, Guerbet Group, Medtron AG and GE Healthcare.